Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Change in Cash (2016 - 2025)

Historic Change in Cash for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $3.5 million.

  • Iradimed's Change in Cash rose 1081.19% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 343.31%. This contributed to the annual value of $2.5 million for FY2024, which is 13014.77% up from last year.
  • As of Q3 2025, Iradimed's Change in Cash stood at $3.5 million, which was up 1081.19% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Iradimed's Change in Cash registered a high of $4.4 million during Q2 2021, and its lowest value of -$15.2 million during Q1 2023.
  • In the last 5 years, Iradimed's Change in Cash had a median value of $2.7 million in 2025 and averaged $339864.4.
  • As far as peak fluctuations go, Iradimed's Change in Cash surged by 43062.35% in 2021, and later tumbled by 167634.74% in 2022.
  • Iradimed's Change in Cash (Quarter) stood at $3.6 million in 2021, then crashed by 34.71% to $2.4 million in 2022, then rose by 27.37% to $3.0 million in 2023, then crashed by 83.0% to $512856.0 in 2024, then surged by 588.37% to $3.5 million in 2025.
  • Its Change in Cash was $3.5 million in Q3 2025, compared to $2.7 million in Q2 2025 and -$1.9 million in Q1 2025.